228 related articles for article (PubMed ID: 25940317)
1. DcR3 suppresses influenza virus-induced macrophage activation and attenuates pulmonary inflammation and lethality.
Huang MT; Chen ST; Wu HY; Chen YJ; Chou TY; Hsieh SL
J Mol Med (Berl); 2015 Oct; 93(10):1131-43. PubMed ID: 25940317
[TBL] [Abstract][Full Text] [Related]
2. Decoy Receptor 3 Inhibits Monosodium Urate-Induced NLRP3 Inflammasome Activation
Pan YG; Huang MT; Sekar P; Huang DY; Lin WW; Hsieh SL
Front Immunol; 2021; 12():638676. PubMed ID: 33746978
[TBL] [Abstract][Full Text] [Related]
3. Decoy receptor 3 suppresses TLR2-mediated B cell activation by targeting NF-κB.
Huang ZM; Kang JK; Chen CY; Tseng TH; Chang CW; Chang YC; Tai SK; Hsieh SL; Leu CM
J Immunol; 2012 Jun; 188(12):5867-76. PubMed ID: 22581854
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis of dendritic cells induced by decoy receptor 3 (DcR3).
You RI; Chang YC; Chen PM; Wang WS; Hsu TL; Yang CY; Lee CT; Hsieh SL
Blood; 2008 Feb; 111(3):1480-8. PubMed ID: 18006694
[TBL] [Abstract][Full Text] [Related]
5. Decoy receptor 3 enhances tumor progression via induction of tumor-associated macrophages.
Tai SK; Chang HC; Lan KL; Lee CT; Yang CY; Chen NJ; Chou TY; Tarng DC; Hsieh SL
J Immunol; 2012 Mar; 188(5):2464-71. PubMed ID: 22287720
[TBL] [Abstract][Full Text] [Related]
6. Decoy receptor 3: an endogenous immunomodulator in cancer growth and inflammatory reactions.
Hsieh SL; Lin WW
J Biomed Sci; 2017 Jun; 24(1):39. PubMed ID: 28629361
[TBL] [Abstract][Full Text] [Related]
7. Single-walled carbon nanotubes modulate pulmonary immune responses and increase pandemic influenza a virus titers in mice.
Chen H; Zheng X; Nicholas J; Humes ST; Loeb JC; Robinson SE; Bisesi JH; Das D; Saleh NB; Castleman WL; Lednicky JA; Sabo-Attwood T
Virol J; 2017 Dec; 14(1):242. PubMed ID: 29273069
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory influence of the hexapeptidic sequence SLIGRL on influenza A virus infection in mice.
Betts RJ; Mann TS; Henry PJ
J Pharmacol Exp Ther; 2012 Dec; 343(3):725-35. PubMed ID: 22988062
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of curcumin on influenza A virus infection and influenzal pneumonia via oxidative stress, TLR2/4, p38/JNK MAPK and NF-κB pathways.
Dai J; Gu L; Su Y; Wang Q; Zhao Y; Chen X; Deng H; Li W; Wang G; Li K
Int Immunopharmacol; 2018 Jan; 54():177-187. PubMed ID: 29153953
[TBL] [Abstract][Full Text] [Related]
10. Myeloid Protease-Activated Receptor-2 Contributes to Influenza A Virus Pathology in Mice.
Gunther RC; Bharathi V; Miles SD; Tumey LR; Schmedes CM; Tatsumi K; Bridges MD; Martinez D; Montgomery SA; Beck MA; Camerer E; Mackman N; Antoniak S
Front Immunol; 2021; 12():791017. PubMed ID: 34925374
[TBL] [Abstract][Full Text] [Related]
11. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
12. Decoy receptor 3 attenuates collagen-induced arthritis by modulating T cell activation and B cell expansion.
Cheng CP; Sytwu HK; Chang DM
J Rheumatol; 2011 Dec; 38(12):2522-35. PubMed ID: 21885501
[TBL] [Abstract][Full Text] [Related]
13. Modulation of macrophage differentiation and activation by decoy receptor 3.
Chang YC; Hsu TL; Lin HH; Chio CC; Chiu AW; Chen NJ; Lin CH; Hsieh SL
J Leukoc Biol; 2004 Mar; 75(3):486-94. PubMed ID: 14657214
[TBL] [Abstract][Full Text] [Related]
14. Intranasal Introduction of Fc-Fused Interleukin-7 Provides Long-Lasting Prophylaxis against Lethal Influenza Virus Infection.
Kang MC; Choi DH; Choi YW; Park SJ; Namkoong H; Park KS; Ahn SS; Surh CD; Yoon SW; Kim DJ; Choi JA; Park Y; Sung YC; Lee SW
J Virol; 2015 Dec; 90(5):2273-84. PubMed ID: 26656713
[TBL] [Abstract][Full Text] [Related]
15. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen.
Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR
J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784
[TBL] [Abstract][Full Text] [Related]
16. Delivery of GM-CSF to Protect against Influenza Pneumonia.
Subramaniam R; Hillberry Z; Chen H; Feng Y; Fletcher K; Neuenschwander P; Shams H
PLoS One; 2015; 10(4):e0124593. PubMed ID: 25923215
[TBL] [Abstract][Full Text] [Related]
17. Decoy receptor 3 analogous supplement protects steatotic rat liver from ischemia-reperfusion injury.
Li TH; Liu CW; Lee PC; Huang CC; Lee KC; Hsieh YC; Yang YY; Hsieh SL; Lin HC; Tsai CY
J Chin Med Assoc; 2017 Jul; 80(7):391-400. PubMed ID: 28325574
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effect of decoy receptor 3 on the differentiation and function of bone marrow-derived dendritic cells in nonobese diabetic mice: from regulatory mechanism to clinical implication.
Wu SF; Liu TM; Lin YC; Sytwu HK; Juan HF; Chen ST; Shen KL; Hsi SC; Hsieh SL
J Leukoc Biol; 2004 Feb; 75(2):293-306. PubMed ID: 14634066
[TBL] [Abstract][Full Text] [Related]
19. Decoy Receptor 3 Suppresses T-Cell Priming and Promotes Apoptosis of Effector T-Cells in Acute Cell-Mediated Rejection: The Role of Reverse Signaling.
Weng SC; Wen MC; Hsieh SL; Chen NJ; Tarng DC
Front Immunol; 2022; 13():879648. PubMed ID: 35720343
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidyl Inositol 3 Kinase-Gamma Balances Antiviral and Inflammatory Responses During Influenza A H1N1 Infection: From Murine Model to Genetic Association in Patients.
Garcia CC; Tavares LP; Dias ACF; Kehdy F; Alvarado-Arnez LE; Queiroz-Junior CM; Galvão I; Lima BH; Matos AR; Gonçalves APF; Soriani FM; Moraes MO; Marques JT; Siqueira MM; Machado AMV; Sousa LP; Russo RC; Teixeira MM
Front Immunol; 2018; 9():975. PubMed ID: 29867955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
